These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7675548

  • 1. [In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin].
    Duez JM, Siebor E, Pechinot A, Cordin X, Chamard-Neuwirth C, Kazmierczak A.
    Pathol Biol (Paris); 1995 Mar; 43(3):208-14. PubMed ID: 7675548
    [Abstract] [Full Text] [Related]

  • 2. [In vitro synergistic activity of piperacillin-tazobactam combination against beta-lactam antibiotics resistant strains of Enterobacteriaceae].
    Duex JM, Cordin X, Péchinot A, Siebor E, Kazmierczak A.
    Pathol Biol (Paris); 1991 May; 39(5):374-8. PubMed ID: 1652728
    [Abstract] [Full Text] [Related]

  • 3. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
    Gatermann S, Marre R.
    Infection; 1991 May; 19(2):106-9. PubMed ID: 1646771
    [Abstract] [Full Text] [Related]

  • 4. [A three-dimensional model for in vitro study of the association of three antibiotics. Application to the activity of piperacillin, tazobactam and amikacin against five strains of enterobacteria as a function of their phenotype of beta-lactam resistance].
    Duez JM, Cordin X, Siebor E, Pechinot A, Chamard-Neuwirth C, Kazmierczak A.
    Pathol Biol (Paris); 1998 Jan; 46(1):67-72. PubMed ID: 9769939
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin.
    Higashitani F, Hyodo A, Ishida N, Inoue M, Mitsuhashi S.
    J Antimicrob Chemother; 1990 Apr; 25(4):567-74. PubMed ID: 2161820
    [Abstract] [Full Text] [Related]

  • 6. Comparative activity of piperacillin/tazobactam against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Pagani L, Migliavacca R, Luzzaro F, Giacobone E, Perilli M, Micheletti P, Amicosante G.
    Chemotherapy; 1998 Apr; 44(6):377-84. PubMed ID: 9755296
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa.
    Lister PD.
    Pharmacotherapy; 2000 Sep; 20(9 Pt 2):213S-218S; discussion 224S-228S. PubMed ID: 11001328
    [Abstract] [Full Text] [Related]

  • 9. Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill.
    Burgess DS, Hastings RW.
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):37-41. PubMed ID: 11025182
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Efficiency of tazobactam as inhibitor of beta-lactamases, combined with piperacillin, against resistant strains to this penicillin].
    Roy C, Tirado M, Teruel D, Reig R, Ràfols M.
    Med Clin (Barc); 1989 Mar 18; 92(10):371-4. PubMed ID: 2541285
    [Abstract] [Full Text] [Related]

  • 12. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).
    Jones RN, Barry AL.
    Diagn Microbiol Infect Dis; 1989 Mar 18; 12(6):495-510. PubMed ID: 2560422
    [Abstract] [Full Text] [Related]

  • 13. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    Mimoz O, Elhelali N, Léotard S, Jacolot A, Laurent F, Samii K, Petitjean O, Nordmann P.
    J Antimicrob Chemother; 1999 Jul 18; 44(1):91-7. PubMed ID: 10459815
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial activities of piperacillin alone and in combination with tazobactam against beta-lactamase-producing bacteria.
    Chang SC, Hsu LY, Luh KT, Hsieh WC.
    J Formos Med Assoc; 1991 Oct 18; 90(10):947-52. PubMed ID: 1685175
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
    Livermore DM, Seetulsingh P.
    J Antimicrob Chemother; 1991 Jun 18; 27(6):761-7. PubMed ID: 1669013
    [Abstract] [Full Text] [Related]

  • 16. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
    Vanjak D, Muller-Serieys C, Picard B, Bergogne-Berezin E, Lambert-Zechovsky N.
    Eur J Clin Microbiol Infect Dis; 1995 Nov 18; 14(11):972-8. PubMed ID: 8654448
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of piperacillin/tazobactam against 615 Pseudomonas aeruginosa strains isolated in intensive care units.
    Bonfiglio G, Laksai Y, Franceschini N, Perilli M, Segatore B, Bianchi C, Stefani S, Amicosante G, Nicoletti G.
    Chemotherapy; 1998 Nov 18; 44(5):305-12. PubMed ID: 9732144
    [Abstract] [Full Text] [Related]

  • 18. [In vitro synergistic effects of tazobactam/piperacillin with various antibiotics].
    Nishida K, Niidome K, Hashimoto M, Otsuki M, Nishino T.
    Jpn J Antibiot; 1994 Oct 18; 47(10):1348-62. PubMed ID: 7807695
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility of beta-lactamase-producing enterococci to piperacillin with tazobactam.
    Okhuysen PC, Singh KV, Murray BE.
    Diagn Microbiol Infect Dis; 1993 Oct 18; 17(3):219-24. PubMed ID: 8112031
    [Abstract] [Full Text] [Related]

  • 20. Antibacterial activity of piperacillin and tazobactam against beta-lactamase-producing clinical isolates.
    Cullmann W, Stieglitz M.
    Chemotherapy; 1990 Oct 18; 36(5):356-64. PubMed ID: 2170081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.